Hepatitis C virus prevention and care for drug injectors: the French approach

After France removed hepatitis C treatment reimbursement restrictions on 25 May 2016, an expert report presented recommendations, which focused on vulnerable groups including people who inject drugs (PWID). This commentary presents the key points of the chapter with a particular focus on policy. Tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Delile, Jean-Michel, de Ledinghen, Victor, Jauffret-Roustide, Marie, Roux, Perrine, Reiller, Brigitte, Foucher, Juliette, Dhumeaux, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987624/
https://www.ncbi.nlm.nih.gov/pubmed/30288330
http://dx.doi.org/10.1186/s41124-018-0033-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987624/
https://www.ncbi.nlm.nih.gov/pubmed/30288330
http://dx.doi.org/10.1186/s41124-018-0033-8

Ejemplares similares